About

Addition Technology, Inc. is a privately held eye care company, specializing in novel solutions for sight-threatening eye indications. Intacs® corneal implants and the AlphaCor™ artificial cornea are patented devices, and the first of their kind, approved by the FDA and granted CE Mark certification in Europe in addressing vision threatening conditions of the cornea. Intacs corneal implants are indicated for keratoconus and myopia. AlphaCor artificial cornea is indicated as an alternative for high-risk, repeat graft failures.